SIRT2 also directs other physiological processes, including gluconeogenesis, insulin sensitivity, and fatty acid oxidation6–8, and is critical for insulin-dependent AKT activation, suggesting that the inhibition of SIRT2 may have an impact on cancer growth9. This evidence concerns the gene INS and cancer.